DMAAU — Drugs Made In America Acquisition Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2028614 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -136,934 | 1,726,897 | 146,903,435 | 20,280 | 9,136,624 |
| Mar 2026 | 0 | — | -143,301 | 1,970,459 | 242,035,303 | 14,887 | 7,392,169 |
| Dec 2025 | 0 | — | -2,089,466 | 212,958 | 239,918,847 | 6,137 | 7,276,172 |
| Sep 2025 | 0 | — | -263,703 | 2,184,563 | 237,632,428 | 717 | 7,356,611 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-379,193
Investing CF
$0
Financing CF
$393,157
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,378,354
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-2,628,389
Pretax Income TTM
$6,656,559
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,816,013 | 5,940,643 | 239,918,847 | 7,276,172 | 232,642,675 | -539,187 |
| Dec 2024 | — | — | — | 550,824 | 795,669 | -244,845 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.68B | $36.44 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $647.19M | $10.16 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $484.03M | $10.31 | — |
| BCSS | Bain Capital GSS Investment Corp. | $483.54M | $10.31 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $472.77M | $10.30 | — |
Recent Insider Activity
No insider activity indexed for this ticker.